Contrarian investors identify three beaten-down sectors with buying opportunities: financials (American Express, KKR, Apollo Global Management, Blue Owl Capital, Robinhood), healthcare (Molina Healthcare, Oscar Health, Hims Hers Health), and software (Microsoft, Oracle, ServiceNow, Figma). They recommend avoiding energy stocks, which have rallied too far on momentum and FOMO despite potential long-term gains.

The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.

Grabar Law Office is investigating securities fraud claims against four companies: ASP Isotopes for allegedly making false statements about uranium enrichment technology; Integer Holdings for overstating competitive position and concealing sales deterioration; Molina Healthcare for failing to disclose adverse medical cost trends; and Soleno Therapeutics for misrepresenting the safety profile of its drug candidate DCCR, which resulted in a patient death.

Grabar Law Office is investigating shareholder claims against four companies for alleged breaches of fiduciary duties and securities fraud. Corcept Therapeutics faces allegations of misrepresenting clinical trial data for its relacorilant drug, which received an FDA Complete Response Letter. Integer Holdings is accused of overstating its competitive position and concealing deteriorating sales. Kyndryl Holdings disclosed SEC investigations into cash management practices and internal control weaknesses. Molina Healthcare allegedly failed to disclose adverse medical cost trends and guidance risks.

The healthcare transportation service market is expected to grow from $116.47 billion in 2026 to $155.26 billion by 2030, with a CAGR of 7.5%. Growth drivers include aging populations, chronic disease prevalence, home healthcare expansion, and AI-powered route optimization. Leading companies include Centene, Molina Healthcare, DHL, ARAMARK, Lyft Healthcare, and ModivCare, with North America currently dominant and Asia-Pacific showing fastest growth.

U.S. stock indices rallied Friday with the Dow Jones surging nearly 2% to a fresh all-time high of 49,870 points, while the Russell 2000 outperformed with a 3% gain. The software-driven sell-off paused after eight consecutive down sessions, with tech stocks rebounding sharply. However, Molina Healthcare crashed 29% on weak earnings guidance, and Amazon fell over 7% despite beating earnings expectations due to concerns over capital expenditures.

Molina Healthcare (NYSE:MOH) shares plunged 33.3% to $118 in after-hours trading following Q4 earnings. The company reported a loss of $2.75 per share, missing analyst expectations of 33 cents, though revenue of $11.38 billion beat estimates. For fiscal 2026, Molina expects adjusted EPS of at least $5 and premium revenue of approximately $42 billion, down 2% from 2025. CEO Joseph Zubretsky noted that 2026 is expected to be a trough year for Medicaid industry margins.

Michael Burry, famous for betting against the housing market, liquidated his UnitedHealth stake in Q3 2025 and rotated heavily into Molina Healthcare, calling it a 'generational buy.' While major insurers faced steep losses following a low 2027 Medicare rate proposal from CMS, Molina fared better than peers due to its 75% Medicaid revenue exposure and disciplined operations. Burry's contrarian bet appears to be paying off early in 2026.

The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.

Michael Burry and Cathie Wood are taking divergent investment approaches in uncertain markets. Burry is betting on Molina Healthcare as an undervalued defensive play in government-backed healthcare programs, comparing it to early-stage GEICO. Meanwhile, Wood is allocating capital toward innovation-driven technologies, recently acquiring positions in Broadcom, Joby Aviation, and Archer Aviation through her ARK ETFs.

On December 30, 2025, major U.S. stock indexes closed near record highs with modest declines in quiet year-end trading. The S&P 500 fell 0.13%, Nasdaq dropped 0.24%, and the Dow eased 0.20%. Boeing led industrials with a 0.6% gain following an $8.5 billion U.S. Air Force contract announcement, while Molina Healthcare jumped 2.5% on positive investor commentary. OceanFirst Financial plunged 6.7% after announcing a merger agreement.

Renowned investor Michael Burry published a detailed investment thesis on Substack arguing that Molina Healthcare is a premier investment opportunity, comparing it favorably to Warren Buffett's acquisition of Geico. Burry highlighted Molina's focus on Medicaid programs, impressive growth potential, and high returns on invested capital, suggesting it has better business prospects than Apple. He noted the company's best-in-class loss ratio, expense ratio, and conservative accounting under CEO Joe Zubretsky, and believes MOH stock could be a generational buy if it falls below $100.